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Background: The PedsQL™3.0 Diabetes Module is a widely used instrument to measure the disease-specific
health-related quality of life summary measures in children and adolescents with type 1 diabetes. After cultural
adaptation, we confirmed reliability and validity of PedsQL™3.0 Diabetes Module in its Italian version.
Methods: Participants were 169 Italian children and adolescents with type 1 diabetes aged 5–18 years and 100
parents. Reliability was determined by internal consistency using Cronbach’s coefficient alpha, and test-retest
reliability by intra-class correlation coefficient (ICC). Validity was assessed through factor validity examined by
exploratory factor analysis, and discriminant validity examined through multitrait/multi-item scaling analysis.
Discriminant validity with respect to dichotomous patients’ characteristics at baseline was also examined
through a multivariate analysis on the summary measures using the Wilks’ Lambda test.
Results: Data completeness was optimal. Item internal consistency was satisfied at 89% for the child self-report
scales and at 100% for the parents’ proxy-report scales. Most diabetes module scales was acceptable for group
comparisons. Discriminant validity was satisfied for 71% of children and adolescents and for 82% of parents.
A ≥70% Cronbach’s α coefficient was found for the summary measures of both reports. For the test-retest reliability,
the ICC coefficients ranged from 0.66 (i.e., the Worry scale) to 0.82 for the other scales of the child self-report. The
ICC coefficients were ≥0.87 for all the parents’ proxy-report scales. Factor analysis showed that the PedsQL™3.0
Diabetes Module for child self-report could be summarized in 10 components, which explained the 62% of the
variance. For the parent proxy-report the statistical analysis selected 9 factors, which explained about 68% of
variance. The external discriminant validity of the PedsQL™3.0 Diabetes Module summary measures were compared
across gender, age, time since diagnosis and HbA1c mean cut off values. Significant differences in the “Treatment
adherence” scale and in the “Communication” scale were observed across age, and by time since diagnosis.
Conclusions: The results show the reliability and validity of the Italian translation of the PedsQL™3.0 Diabetes
Module, supporting therefore its use as an outcome measure for diabetes cross-national clinical trials and research.
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In the last decade, quality of life (QOL) has emerged as an
important health objective in diabetes management, being
positively related to degree of metabolic control [1,2]. Ac-
cording to the World Health Organization, health is a
state of complete physical, mental and social well-being
and not merely the absence of disease or infirmity [3].
Therefore, a health-related quality of life (HRQOL) meas-
urement should include physical, mental and social health
aspects, be based on different age patient’s perception,
and provide evidence of acceptance and reliability. In
the perspectives of the health care provider, HRQOL is
increasingly becoming a recognized measure of treat-
ment outcome based on the concept that an illness affects
all domains of the patient’s and family’s life. Moreover, ac-
cording to the FDA Guidelines [4], HRQOL measure-
ment by means of validated questionnaires is an essential
outcome in clinical research in different settings as in
pediatrics for international observational studies and clin-
ical trials [5].
Juvenile diabetes management involves young patients
and all family members, and can interfere with familiar
dynamics and habits, affecting both patients’ and parents’
HRQOL [1,2]. The availability of parent-proxy report
scales is essential to obtain complementary information in
juvenile diabetes HRQOL matters. As a consequence, sev-
eral generic and disease-specific instruments to measure
HRQOL have been developed and validated in diabetes.
The Pediatric Quality of Life Inventory (PedsQL™) is a
modular instrument for measuring HRQOL in children
and adolescents ages 2 to 18 [6]. The PedsQL™4.0 Generic
Core Scales are multidimensional child self-report and
parent proxy-report scales developed as the generic core
measure to be integrated with the PedsQL™ Disease-
Specific Modules into a one-measurement system. The
PedsQL™4.0 Generic Score Scales distinguish between
healthy children and those affected by acute or chronic dis-
eases and provide evidence of good feasibility, reliability
and sensitivity to different diseases in several reports [7-9].
The PedsQL™3.0 Diabetes Module questionnaire has been
assessed to measure diabetes-specific QOL dimensions in
both children and their parents: either PedsQL™4.0 or
PedsQL™3.0 Diabetes Module have been tailored for a
broad age range including child self-report for ages 5–18
years, and parents’ proxy-report for their children for ages
2–18 years [10]. Recently, feasibility, reliability and validity
of the new electronic version of e-PedsQL™ for type 1 and
type 2 diabetes has been successfully demonstrated [11].
Due to the complex construction of each instrument,
these measures cannot be assumed to be invariant to cul-
tural diversity, thus requiring cultural adaptation [12], and
verification of their psychometric properties [13-15]. The
PedsQL™3.0 Diabetes Module questionnaire has already
been translated and validated for many languages althoughnot yet in Italian (see the listing of existing translations
available from http://www.pedsql.org/PedsQL-Transla-
tion-Tables.doc. Accessed February 18, 2014).
The purpose of the present study was the translation, its
cultural adaptation and statistical validation of the Italian
version of the PedsQL™3.0 Diabetes Module questionnaire
for a broad age range including children’s and adolescents’
self-reports for ages 5–18 years, and parents’ proxy-reports
for their children for ages 5–18 years from six Italian
pediatric centers for diabetes.
Methods
The questionnaire
The PedsQL™3.0 Diabetes Module includes 28 items
distributed into 5 scales: 1) Diabetes symptoms (11 items);
2) Treatments barriers (4 items); 3) Treatment adherence
(7 items); 4) Worry (3 items); 5) Communications (3 items).
The child instrument differs by age group: 5 to 7, 8 to 12
and 13 to 18 years. The parent’s version also differs by
child’s age group: 2 to 4, 5 to 7, 8 to 12 and 13 to 18 years.
The items for each of the forms are essentially identical,
differing in developmentally appropriate language, or first-
person or third-person tenses.
The goals of the translation and cultural validation of
the questionnaire text contents were to develop a ver-
sion of the PedsQL™3.0 Diabetes Module that sounded
natural in Italian, conceptually equivalent to the original
US English version, and easy to understand and to answer
for Italian children with type 1 diabetes. Translation and
cultural validation were performed according to the guide-
lines provided by the MAPI Research Trust (at http://
www.pedsql.org/PedsQL-Linguistic-Validation-Guidelines.
doc). After minor modifications of the local translation,
the Italian final version of the PedsQL™3.0 Diabetes
Module was produced. All translation procedures were
reported to the MAPI Research Trust, to rate the
equivalence between the final Italian version and the
original US English version.
Study population
The eligible patients were on intensified basal-bolus insu-
lin therapy or on continuous subcutaneous insulin infu-
sion. No Italian-speaking subjects or those with linguistic
problems, and those with any comorbidity that would
have affected outcomes or care (i.e., chromosomopathy,
and neurological impairment) were excluded. The psych-
ologist SG of the coordinating center provided training
material (i.e., written standardized procedures and instruc-
tions via conference calls) to colleagues at the participating
centers. Written informed assents and consents were ob-
tained by minors aged ≥12 years and parents, respectively,
prior to study entry. The questionnaires were randomly ad-
ministered to children and parents during follow-up visits
at the six participating centers with proved experience in
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Italian Society of Pediatric Endocrinology and Diabetes
(ISPED) (Catania, Florence, Genoa, Naples, Rome,
Turin). Patients and parents completed the question-
naires separately. The Ethical Committees of all centers
approved this study.
Psychometric evaluation and statistical analyses
The evaluation of the psychometric properties of the
Italian version of the questionnaire involved the follow-
ing steps:
1. Scoring of the PedsQL™3.0 Diabetes Module
according to the scoring manuals. For each item the
5-point response scale (0 = never a problem; 1 =
almost never a problem; 2 = sometimes a problem;
3 = often a problem; 4 = almost always a problem)
was reversed and linearly transformed in a 0–100
scale where 0 = 100, 1 = 75, 2 = 50, 3 = 25, and 4 = 0.
Therefore, higher scores indicate better QOL. For
each questionnaire scale, the score was summed up
and divided by the number of items answered.
2. Evaluation of completeness at item and scale levels.
3. Calculation of the scale level descriptive statistics, i.e.
mean and 95% confidence intervals (CI), and
percentage of ceiling and floor.
4. Evaluation of internal consistency or reliability – i.e.,
the Cronbach’s α coefficient (α = k x r /[1 + (k - 1) x r];
with k = number of items and r =mean correlation)
[16], and the Squared Multiple Correlation (SMC)
index, which were calculated for each item and for
each scale.
5. Evaluation of the multitrait/multi-item correlation
matrix to assess the items’ internal consistency by
means of the Pearson correlation coefficient; the
equality of item-scale correlations; the items’
discriminant validity.
6. Evaluation of the test-retest correlation for temporal
stability in a two-week interval by means of the
intra-class correlation (ICC) coefficient.
7. Evaluation of the aggregating dimensions of the
PedsQL™3.0 Diabetes Module scales by means of a
factor analysis (principal components, oblique
rotation – i.e., oblimin).
8. Evaluation of the discriminant validity of the
questionnaire with respect to the dichotomous
patients’ characteristics (sex, time since
diagnosis ≤1 year or >1 year, mean value of
HbA1c ≤7.5 mg/dL or >7.5 mg/dL) by performing the
Student’s t test and the 95% CI of the mean difference
for each scale and a multivariate analysis on the
summary measures using the Wilks’ Lambda test.
Discrimination ability of the questionnaire with
respect to patient ages according to the questionnaires(5–7 years, 8–12 and 13–18 years) was analysed for
each scale using an ANalysis Of VAriance (ANOVA),
and the appropriate multiple comparisons between
groups. The 95% CI of each group’s means and of
the between-group differences were calculated. A
multivariate analysis on the summary measures was
also performed using the Wilks’ Lambda test.
The BMDP statistical software (University of California
Press, Release 2009 - Berkeley, Los Angeles, Oxford) was
used for computation.
Results study population
Between November 2011 to June 2012, 172 Italian chil-
dren and adolescents with type 1 diabetes aged 5–18 years
and 104 parents were recruited. The statistical analysis
was performed on data from questionnaires of 169 chil-
dren and 100 parents, having excluded three patients and
four parents who did not satisfy an eligibility criterion
(child’s time since diabetes diagnosis ≥ 3 months). Partici-
pants’ characteristics are reported in Table 1.
Translation and cultural validation
The nomenclature of the scales did not need any modifi-
cation. Comparing the back-translations with original ver-
sions, 13 items were rephrased by the translators, together
with the psychologist SG and the study principal investiga-
tor. During the test, the psychologist verified the due intel-
ligibility of the items in the questionnaire: two items were
rephrased with the help of patients, parents and the psych-
ologist to increase the clarity.
Psychometric evaluation and statistical analysis
Completeness was optimal both at the item and scale
level (i.e., the percentage of missing item responses was
0.04 in both children and parents), with almost 100% of
items answered and scales completed. Table 2 shows the
mean and 95% CI for the scales belonging to child self-
report and parents’ proxy-report scales. The means of
each scale were quite similar, except for the “Treatment
barriers” scale for which parents’ proxy-report scale
showed a significant lower score. A Cronbach’s α coeffi-
cient <70% was recorded for all the items in the child self-
report scale (range 0.62 - 0.67), and for the “Diabetes
symptoms”, “Treatment barriers” and “Communication” of
parents’ proxy-report scales (Table 2). The proportion of
patients with a floor effect ranged from 0% to 3% in the
child self-report scales, and from 0% to 4% in the parent
proxy-report scales. The proportion of patients with a
ceiling effect ranged from 0.6% to 24% in the child self-
report scales and from 2% to 23% in the parents’ proxy-
report scales. The Pearson’s correlation coefficient for
the item internal consistency was satisfied at 89% and
100% for the child self-report and parents’ proxy-report
Table 1 Participants’ characteristics
Catania Florence Genoa Naples Rome Turin Totals
Children- male, N (%) 8 (67%) 18 (51%) 35 (57%) 9 (56%) 11 (34%) 9 (69%) 90 (53%)
Age, 5–7 yers, N (%) 11 (92%) 5 (14%) 5 (8%) 7 (44%) 5 (16%) 11 (85%) 44 (26%)
Age, 8–12 years, N (%) 1 (8%) 25 (71%) 22 (36%) 7 (44%) 24 (75%) 2 (15%) 81 (48%)
Age, 19–18 years, N (%) n.a. 5 (14%) 34 (56%) 2 (13%) 3 (9%) n.a. 44 (26%)
HbA1c≤ 7.5%, N (%) 6 (50%) 17 (49%) 17 (28%) 2 (13%) 17 (53%) 6 (46%) 65 (38%)
HbA1c≤ 7.5%, N (%) 6 (50%) 18 (51%) 44 (72%) 14 (88%) 15 (47%) 7 (54%) 104 (62%)
Type 1 diabetes duration (≥3 months - <1 year), N (%) 1 (8%) 3 (9%) 2 (3%) n.a. 5 (16%) 2 (15%) 13 (8%)
Type 1 diabetes duration (>1 year), N (%) 11 (92%) 32 (91%) 59 (97%) 16 (100%) 27 (85%) 11 (85%) 156 (92%)
Parents
Mothers, N (%) n.a. n.a. 23 (60.5%) 12 (75%) 13 (65%) 7 (54%) 55 (55%)
Fathers, N (%) n.a. 9 (69%) 8 (21%) 4 (25%) 1 (5%) 2 (15%) 24 (24%)
Both, N (%) n.a. 4 (31%) 7 (18%) n.a. 6 (30%) 4 (31%) 21 (21%)
HbA1c: mean values of glycosylated haemoglobin observed during the previous year; N.: number; n.a.: not available.
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for 71% and 82% of items. Internal consistency was ad-
equate with a Cronbach’s α coefficient ≥70% for the total
scores of both reports. There is no evidence of item over-
lap by the evaluation of the multitrait/multi-item correl-
ation matrix to assess the items’ internal consistency. The
inter-correlations between the child self-report and par-
ents’ proxy-report scales ranged from 0.28 to 0.54, being
most of them in the medium effect size range. “Diabetes
symptoms” and “Treatments barriers” scales had the stron-
gest correlations. For test-retest reliability, a subset of
patients (n = 94) and parents (n = 17) completed the
PedsQL™3.0 Diabetes Module during a routinely scheduledTable 2 Scale descriptive and internal consistency for PedsQL
proxy-reports
95%
Subscale N. of items N. Mean Lower limit
Child self-report
Diabetes self symptoms 11 169 64.69 62.31
Treatment barriers 4 169 79.22 77.11
Treatment adherence 7 169 82.35 80.25
Worry 3 169 66.91 63.47
Communicationn 3 169 73.42 69.64
Total score 28 169 73.32 71.33
Parent proxy report
Diabetes symptoms 11 100 67.75 64.59
Treatment barriers 4 100 71.19 67.21
Treatment adherence 7 100 80.03 77.24
Worry 3 100 66.58 61.43
Communication 3 100 74.25 96.57
Total score 28 100 71.96 96.21
N.: number of participants; S.D.: standard deviation; SMC: Squared Multiple Correlatclinic visit in approximately 10 minutes after maximum
two weeks since the first questionnaire administration. The
ICC ranged from 0.66 to 0.82 for all items of the child self-
report scales, the “Worry” scale only having a value <70%.
For the parents’ proxy-report scales, the ICC ranged from
0.87 to 0.99 for all items (Table 3).
Factor analysis showed that the PedsQL™3.0 Diabetes
Module for child self-report could be summarized into 10
components, which explain the 62% of the variance. The
“Diabetes symptoms” items were split into 5 different fac-
tors, “Treatment barriers” into 2, “Treatment adherence”
into 3, “Communication” into 2, while “Worry” was repre-
sented by one factor only (Table 4). For the parent proxy-™ 3.0 Diabetes Module child self-reports and parent
C.I.
Upper limit S.D. Min. Max. SMC Cronbach’s α
67.06 15.65 9.09 100 0.28 0.61
81.32 20.02 0.00 100 0.23 0.64
84.46 13.89 42.86 100 0.20 0.65
70.36 22.70 0.00 100 0.18 0.67
77.21 24.93 0.00 100 0.20 0.65
75.30 13.07 20.79 97.24 0.69
70.91 15.92 20.46 100 0.4146 0.65
75.14 20.06 0 100 0.5107 0.64
82.82 14.05 28.57 100 0.2368 0.71
71.74 25.99 0 100 0.0976 0.78
78.93 23.60 0 100 0.3748 0.69
74.71 13.87 27.19 95.68 0.74
ion (Index); 95% C.I.: 95% confidence intervals.
Table 3 Test-retest reliability ICCs for child self-reports*
and parent proxy-reports*







































*Reported for ages 5 years and older.
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explained about 68% of variance; “Diabetes symptoms”,
“Treatment barriers” and “Treatment adherence” were split
into 4 factors, “Communication” into 2, and “Worry” was
the only measure described by only one factor (Table 5). Toassess external discriminant validity of PedsQL™3.0 Dia-
betes Module, the “Diabetes symptoms”, “Treatments
barriers”, “Treatment adherence”, “Worry” and “Com-
munication” summary measures were compared across
gender, age, time since diagnosis and HbA1c mean cut
off values. Results are summarized in Figures 1 and 2.
Differences in “Treatment adherence” were observed by
age group: the mean value of children aged >12 years
was statistically different when compared to that of
group aged ≤7 years (p < 0.05) and group aged >7 years
and ≤12 year (p < 0.01). Differences in “Communica-
tion” were observed by age: the mean value of children
aged >12 years was statistically different in comparison
with that of the group aged ≤7 years (p < 0.01) and the
group aged >7 and ≤12 years (p < 0.05). Differences in
“Treatment adherence” were observed for time since diag-
nosis: the mean value of the group diagnosed ≤1 year was
statistically different when compared to that with >1 year
since diagnosis (p < 0.05); lower scores were observed for
the group with >1 year since diagnosis.
Discussion
The results of the current study showed the reliability
and validity of the PedsQL™3.0 Diabetes Module ques-
tionnaire in its Italian version after cultural adaptation
of the disease-specific HRQOL summary measures, i.e.,
“Diabetes symptoms”, “Treatments barriers”, “Treatment
adherence”, “Worry” and “Communication” in children
and adolescents with type 1 diabetes. After an independ-
ent forward and backward translation of the validated
US English version, the Italian version of PedsQL™3.0
Diabetes Module was tested in 169 Italian children and
adolescents with type 1 diabetes aged 5–18 years and
100 parents by trained psychologists in the context of a
multicenter observational longitudinal study. Even if
complex and time requiring, the translational step-wise
algorithm of the validation procedure according to the
MAPI Research Trust allowed us to produce an Italian
version of PedsQL™3.0 Diabetes Module which sounded
user-friendly and easy to understand, culturally adapted
for the country where it will be used, and conceptually
similar to the original US English version. The main
strength of this study was the enrollment of a wide range
of children and parents willing to participate from Italian
Northern-to-Southern regions at the six ISPED centers
with proved experience in pediatric type 1 diabetes man-
agement. Therefore, the validating population represented
the general Italian population of pediatric patients with
type 1 diabetes.
The study aimed at validating the PedsQL™3.0 Diabetes
Module questionnaire for use in Italy, rather than describ-
ing the QOL of pediatric patients with type 1 diabetes.
Thus, the use of convenience sample should not impair
our conclusions. Still, further applications of this version
Table 4 PedsQL™ 3.0 diabetes module questionnaire factor loadings for child self-reports*
Item Factor 1 Factor 2 Factor 3 Factor 4 Factor 5 Factor 6 Factor 7 Factor 8 Factor 9 Factor 10
Diabetes symptoms
1 0.07 0.081 0.055 0.652 0.173 0.089 −0.216 0.013 −0.103 0.06
2 −0.136 0.191 −0.048 0.149 0.576 −0.031 −0.052 −0.219 0.06 0.207
3 0.099 0.152 0.046 −0.114 0.439 0.321 −0.005 −0.169 −0.078 0.327
4 0.047 −0.049 0.073 0.056 −0.038 0.097 −0.032 0.005 −0.11 0.811
5 0.115 0.149 −0.154 0.02 0.089 0.117 0.013 0.666 −0.005 0.037
6 −0.118 0.745 0.072 −0.008 −0.033 0.078 −0.059 0.326 −0.134 −0.155
7 −0.021 0.368 0.078 0.291 0.221 −0.101 −0.028 0.283 −0.06 0.174
8 0.084 0.744 −0.052 −0.089 −0.055 −0.015 0.001 −0.097 0.33 0.065
9 0.149 0.603 −0.061 0.368 −0.004 0.01 0.211 −0.206 0.067 0.077
10 0.201 −0.037 0.052 0.032 −0.041 −0.024 0.163 0.35 0.086 0.391
11 0.23 0.053 −0.04 0.435 0.01 0.068 0.052 0.099 0.241 0.235
Treatment barriers
1 0.049 0.156 0.504 −0.191 −0.197 0.079 −0.159 0.384 0.132 0.058
2 −0.012 −0.105 0.796 −0.01 −0.039 −0.011 −0.09 −0.175 0.124 0.231
3 0.218 −0.156 0.131 0.335 −0.037 0.136 0.095 0.015 0.544 −0.135
4 −0.008 −0.034 0.547 0.355 0.008 0.005 0.143 0.246 0.269 −0.182
Treatment adherence
1 0.015 0.169 0.084 −0.133 0.115 0.006 −0.004 −0.036 0.733 −0.061
2 0.315 0.005 0.123 −0.478 0.493 0.093 0.005 0.169 0.046 −0.011
3 −0.174 0.084 −0.016 0.037 0.169 0.038 0.531 0.156 0.254 0.239
4 0.131 0.032 0.429 0.371 0.066 0.019 0.432 −0.025 −0.299 −0.09
5 −0.017 −0.025 −0.075 −0.094 −0.091 0.117 0.79 −0.133 −0.008 −0.111
6 0.027 −0.165 −0.047 0.063 0.735 −0.02 0.099 0.136 0.075 −0.155
7 −0.046 0.016 0.073 −0.164 0.201 −0.143 0.462 0.293 −0.038 0.162
Worry
1 0.274 0.061 −0.154 0.039 −0.03 0.656 0.13 0.016 −0.144 −0.062
2 −0.176 0.001 0.039 −0.089 −0.085 0.778 0.032 −0.011 0.081 0.16
3 −0.122 −0.108 0.184 0.253 0.229 0.575 −0.126 0.179 0.156 −0.078
Communication
1 0.795 −0.009 0.057 0.075 −0.141 −0.007 −0.042 0.005 0.047 0.054
2 0.867 −0.004 −0.023 −0.044 0.121 −0.044 −0.068 0.056 0.023 0.039
3 0.263 0.244 0.567 −0.075 0.145 0.098 0.121 −0.315 −0.135 0.135
*Reported for ages 5 years and older.
PedsQL™3.0 for child self-reports could be summarized into 10 components, which explain the 62% of the variance. Eingenvalue cut off value: 1.0; bold = highest
factor loading for each item.
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population (Study EudraCT No. 201001923710), is war-
ranted to confirm our results.
The psychometric properties of the Italian version may
be considered satisfying. The mean scores in the different
scales were comparable to those of the original version
[10], and so were the scales with relevant percentages of
ceiling or floor according to the IQOLA project approach
[13]. In term of feasibility, time required to complete ques-
tionnaires was around 10–15 minutes. Items of thePedsQL™3.0 Diabetes Module had minimal missing re-
sponses, suggesting that patients and parents were able to
provide easily QOL data. Similar observation was reported
by Varni who evaluated the PedsQL™ in type 1 and type 2
diabetes [10], and in the more recent electronic version
[11]. The PedsQL™3.0 Diabetes Module item internal
consistency (i.e., the percentage of items with Pearson
item-scale correlation ≥40%) was satisfied at 89% for the
child self-report scales and 100% for the parents’ proxy-
report scales. Discriminant validity (i.e., the percentage of
Table 5 PedsQL™ 3.0 Diabetes Module questionnaire Factor Loadings for parent proxy-reports*
Item Factor 1 Factor 2 Factor 3 Factor 4 Factor 5 Factor 6 Factor 7 Factor 8 Factor 9
Diabetes symptoms
1 0.402 0.278 0.529 −0.155 −0.042 0.045 0.107 0.042 0.181
2 0.209 0.052 0.83 0.175 −0.043 −0.025 0.089 0.007 −0.186
3 0.035 0.079 0.838 0.091 0.186 0.153 0.155 0.077 0.054
4 0.074 0.151 0.276 0.283 0.12 0.055 −0.111 0.719 0.147
5 0.397 0.325 0.149 −0.178 −0.098 0.129 −0.022 0.584 0.215
6 0.76 −0.032 −0.088 0.221 0.045 −0.046 0.143 0.2 −0.111
7 0.681 0.183 0.158 0.045 0.166 −0.039 0.254 0.065 0.057
8 0.466 0.154 0.012 0.172 0.07 0.333 0.021 0.128 0.562
9 0.675 0.015 0.269 0.085 0.153 0.123 −0.21 −0.107 0.044
10 0.434 0.386 0.188 0.023 0.02 0.108 0.042 0.016 −0.007
11 0.449 0.256 0.34 0.04 0.107 0.051 0.295 0.124 0.081
Treatment barriers
1 0.215 0.085 0.192 0.635 0.17 −0.041 0.199 0.049 0.425
2 0.031 0.1 0.168 0.11 −0.01 0.114 0.86 0.097 0.09
3 0.081 0.638 0.293 −0.056 0.034 0.192 0.176 0 0.205
4 0.112 0.524 0.237 −0.125 0.103 0.404 0.341 0.032 −0.05
Treatment adherence
1 −0.035 0.231 0.094 0.735 0.055 0.171 −0.124 0.006 −0.188
2 0.239 0.013 0.008 0.772 0.06 0.107 0.184 0.012 0.134
3 −0.014 0.207 0.024 0.013 0.222 0.664 0.063 0.074 0.079
4 0.317 0.318 0.198 −0.016 0.013 0.325 0.003 0.136 −0.526
5 0.026 −0.006 −0.174 −0.069 0.145 0.148 0.255 0.688 −0.239
6 −0.13 −0.073 0.044 0.348 −0.076 0.629 0.05 0.268 −0.138
7 0.16 −0.033 0.059 0.055 −0.115 0.77 0.008 −0.018 0.011
Worry
1 0.396 0.213 −0.047 0.198 0.674 −0.023 −0.069 0.015 0.094
2 0.055 −0.003 0.03 0.038 0.876 0.087 0.053 −0.045 0.019
3 0.039 −0.104 0.126 −0.007 0.8 −0.041 0.093 0.201 −0.036
Communication
1 0.081 0.697 0.021 0.454 −0.126 0 0.099 0.069 0.043
2 0.134 0.784 −0.075 0.217 0.033 −0.106 0.079 0.202 −0.187
3 0.252 0.393 0.139 0.091 0.162 −0.017 0.649 −0.041 −0.103
*Reported for ages 5 years and older.
PedsQL™3.0 for parent proxy-reports could be summarized into 9 components, which explain the 68% of the variance. Eingenvalue cut off value: 1.0; bold =
highest factor loading for each item.
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http://www.hqlo.com/content/12/1/115items with higher Pearson correlation with other scales
than with its own scale) was satisfied at 71% for the child
self-report scales and at 82% for the parents’ proxy-report
scales, respectively. The internal consistency reliabilities of
PedsQL™3.0 Diabetes Module self-report and proxy-report
as summary measures satisfied the recommended mini-
mum α-coefficient standard of 0.70 for group comparisons
[13]. For the items of the child self-report scales, they
all were in the 0.60-0.70 range, while for the parents’
proxy-report item scales, “Diabetes symptoms”, “Treatmentbarriers”, and “Communication” ranged between 0.64-0.69.
Strong correlation between the child self-reports and par-
ents’ proxy-reports was showed between the same scales,
with the exception of “Treatment adherence”, the evalu-
ation of diabetes symptoms than emotional symptoms be-
ing the reason for this objectivity and easiness. The number
of test items, item interrelatedness and dimensionality
affect the value of alpha [17]. Although Cronbach alpha
represents the lower bound of the reliability of a meas-
urement instrument, and is a conservative estimate of
Figure 1 Discrimination ability of the questionnaire with respect to grouped ages of patients. Mean summary scores for three groups of
children (i.e., 5–7 year-, 8–12 year-, and 13–18 year-old subjects) are compared. Significant differences in the “Treatment adherence” and the
“Communication” scales were observed in the 13–18 year-old group.
d’Annunzio et al. Health and Quality of Life Outcomes 2014, 12:115 Page 8 of 10
http://www.hqlo.com/content/12/1/115actual reliability [18], scales that did not approach or
meet the 0.70 standard should be used only for descrip-
tive analyses.
Test-retest reliability was performed in a two-week
interval, which was deemed adequate [19], having as-
sumed that fluctuations due to external factors, such as
disease and treatment variables, were unlikely and not ex-
pected to influence the scale functioning. ICC values
among the children ranged from good to excellent except
for the “Worry” scale. The ICC values for the parents’
proxy-report were excellent, despite the returned 30-50%
of retest questionnaires was not met.
Validity was also assessed through factor validity and
clinical/external discriminant validity. A factor analysis
(principal components, oblique rotation - oblimin) forFigure 2 Discrimination ability of the questionnaire with respect to ti
(i.e., either time since diagnosis ≤1 year or >1 year) are compared. A signifdetermining the items’ scale structure of an instrument
along with assessment of items’ conceptual clarity was
performed on PedsQL™3.0 Diabetes Module for child
self-reports and parent proxy-reports to verify aggregat-
ing dimensions. This exploratory multivariate technique
allows data reduction, i.e., it reduces the number of vari-
ables in an analysis by describing linear combinations of
the variables that contain most of the information with
(possibly) meaningful interpretation. The coefficients esti-
mated from the linear combinations are called factor load-
ings. Factors were selected if their eingenvalue was ≥ 1.
The variance explained by each factor is the eigenvalue for
that factor. Although the original US English version has a
five factor structure [10], exploratory factor analysis identi-
fied 10 factors for child self-reports and 9 factors forme since diagnosis. Mean summary scores for two groups of patients
icant difference in the “Treatment adherence” scale was observed.
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http://www.hqlo.com/content/12/1/115parent proxy-reports in our Italian version, as detailed in
Table 3. Our findings are consistent with those from stud-
ies reporting on the factor structure of the original US
English version [20,21], and thus support the psychometric
properties of the Italian translation version of the measure.
As already reported by Nansel [20], parallel parent and
child scales did not emerge. The factor structure of the
PedsQL™3.0 Diabetes Module did not support the original
five-factor scales. As reported by other authors [21], the
findings indicate that the module is most reliable when
used as one scale rather than five sub-scales. The external
discriminant validity of the PedsQL™3.0 Diabetes Module
summary measures were compared across gender, age,
time since diagnosis and HbA1c mean cut off values. Sig-
nificant differences in the “Treatment adherence” scale
and in the “Communication” scale were observed across
ages and by time since diagnosis.
Conclusions
This study showed the reliability and validity of the Italian
version of the PedsQL™3.0 Diabetes Module questionnaire,
that is easy to understand and reduces possible cultural
biases to a minimum. Therefore, this module could be
used as an outcome measure for diabetes cross-national
clinical trials and research.
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